We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
84 hedge funds and large institutions have $320M invested in Madrigal Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
84% more call options, than puts
Call options by funds: $9.41M | Put options by funds: $5.12M
28% more capital invested
Capital invested by funds: $249M → $320M (+$70.6M)
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding
Funds holding: 84 → 84 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
2.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
32
Reduced
25
Closed
12
Calls
$9.41M
Puts
$5.12M
Net Calls
+$4.3M
Net Calls Change
-$3.63M
Top Buyers
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$5.46M |
| 2 |
QF
QVT Financial
New York
|
-$4.14M |
| 3 |
Goldman Sachs
New York
|
-$1.96M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.9M |
| 5 |
Jane Street
New York
|
-$1.41M |
